Neuroimmunological function in parents of children suffering from cancer

Noa Benaroya-Milshtein1, Alan Apter, Isaac Yaniv

  • 1The Department of Child and Adolescent Psychiatry, Schneider Children's Medical Center of Israel, 49202, Petah Tikva, Israel, nbenaroya@gmail.com.

Insights

Parents of children with cancer experiencing depression show altered immune function, including higher CD8 cell percentages and lower CD4/CD8 ratios. This highlights the significant psychological and physiological impact of cancer on caregivers.

Area of Science:

  • Psychoneuroimmunology
  • Pediatric Oncology

Background:

  • Parental mental health is crucial during childhood cancer treatment.
  • Stress and depression in parents can impact their well-being and potentially their immune system.

Purpose of the Study:

  • To investigate the relationship between depression and immunological function in parents of children with cancer.
  • To assess how stress, depression, and quality of life relate to immune markers in this population.

Main Methods:

  • Thirty-two parents completed questionnaires assessing stress, depression (Beck Depression Inventory II), and quality of life.
  • Blood samples were analyzed for cortisol levels and lymphocyte subgroups (CD4, CD8).
  • Participants were categorized into depressed (DP) and non-depressed (non-DP) groups based on depression scores.

Main Results:

  • Depressed parents (DP) reported significantly higher stress and dysfunction scores.
  • DP group exhibited higher CD8 percentages and lower CD4 percentages and CD4/CD8 ratios compared to non-DP.
  • Depression scores correlated positively with stress/dysfunction and negatively with quality of life and CD4/CD8 ratio.

Conclusions:

  • Parents of children with cancer exhibit high psychiatric morbidity.
  • Depression in these parents is associated with significant alterations in immune function.
  • These findings suggest that stress and depression can physiologically impact immune responses in caregivers.

Related Concept Videos

Psychoneuroimmunology: Diabetes and Cancer01:19

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...
536
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.6K
T Cell Types and Functions01:24

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
3.2K
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
65.0K
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K